Status:
COMPLETED
Analyses of Human Samples Collected in Clinical Trials
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Leukemia, Myeloid
Neoplasm Metastasis
Eligibility:
All Genders
Up to 100 years
Brief Summary
Cancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes. The purpose of this study is to conduct further analyse...
Detailed Description
Various human samples (e.g., serum, plasma, whole blood, erythrocytes, urine, feces, bile, and/or saliva) will be collected from cancer patients enrolled on approved clinical trials, in accordance wit...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Any patients entered on approved trials of cancer therapeutics or agents that are commonly administered to patients with cancer at institutions outside of the intramural NCI are eligible for inclusion, provided that they have consented to pharmacological analysis in the original consent form.
- EXCLUSION CRITERIA:
- None anticipated at this time.
Exclusion
Key Trial Info
Start Date :
July 2 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 26 2020
Estimated Enrollment :
2579 Patients enrolled
Trial Details
Trial ID
NCT00339664
Start Date
July 2 2003
End Date
March 26 2020
Last Update
March 30 2020
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens National Medical Center
Washington D.C., District of Columbia, United States
2
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States, 33612
3
University of Chicago
Chicago, Illinois, United States, 60637
4
University of Maryland, Baltimore
Baltimore, Maryland, United States, 21201-1595